150P Adjuvant BEP/EP versus carboplatin-paclitaxel in adult granulosa cell tumor of the ovary: A multicenter analysis of survival and toxicity
Adult granulosa cell tumors (AGCTs) are rare ovarian sex cord-stromal tumors, and the role of adjuvant chemotherapy remains uncertain. We compared disease-free survival (DFS) and toxicity between bleomycin-etoposide-cisplatin/etoposide-cisplatin (BEP/EP) and carboplatin-paclitaxel (CP).
Authors
- T. Ugur
- E. Goker
- A. Gecgel
- Z. Arik
- S. Ay
- S. Ön
- T. Kaya
- M. Uzun
- E. Kavvasoglu Durmus
- O. Sutcuoglu
- Y.E. Surgen
- M.B. Kaya
- C. Kelten Talu
Institutions
- Ege University (TR)
- Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR)
- Izmir Tepecik Eğitim ve Araştırma Hastanesi (TR)
- Hacettepe University (TR)
- Gazi University (TR)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-07-01
- DOI
- https://doi.org/10.1016/j.esmoop.2026.108197
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00